A B S T R A C T Myocardiopathy is commion in uremia, but its cause is unknown. Excessive entry of calcium in heart cells by catecholamines has been shown to cause necrosis of myocardium. The high blood levels of parathyroid hormone (PTH) in uremia may also enhance entry of calcium into heart cells and exert deleterious effects on the heart. We examined the effect of PTH on rat heart cells grown in culture. Both amino-terminal (1-34) PTH and intact (1-84) PTH, but not the carboxy-terminal (53-84) PTH produced immediate and sustained significant rise in beats per minute and the cells died earlier than control. The effect was reversed if PTH was removed from medium, and was abolished by inactivation of the hormone. There was a dose-reponse relationship between both moieties of PTH and the rise in heart beats, but the effect of 1-84 PTH was significantly greater than that of 1-34 moiety. PTH stimulated cyclic AMP production within 1 min, and cyclic AMP remained significantly elevated thereafter. The effect of PTH required calcium, was mimicked by calcium ionophore, was prevented by verapamil and was not abolished by a-or ,8-adrenergic blockers. PTH action was additive to phenylephrine and synergistic with isoproterenol. Sera from uremic parathyroidectomized rats did not affect heart beats, but sera from uremic rats with intact parathyroid glands or from uremic-parathyroidectomized rats treated with PTH had effects similar to PTH. Data indicate that (a) heart cell is a target organ for PTH and may have receptors for the hormone; (b) PTH increases beating rate of heart cells and causes early death of cells; (c) PTH effect appears to be due to calcitum entry into heart cells; (d) the locus of action through which PTH induces calcium entry is different from that for catecholamines;
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INTRODUCTION
Patients with advanced renal failure may suffer from myocardial disease (1) (2) (3) (4) (5) (6) . Several consequences of uremiia have been implicated, such as anemia, electrolyte disturbances, acidosis, and hypertension (5, 7) . Accelerated atherogenesis has also been suggested as the cause of heart disease in these patients (8) . However, myocardiopathy of unexplained etiology has also been reported (6) .
Patients with renal failure have secondary hyperparathyroidism (9) (10) (11) , and markedly elevated blood levels of parathyroid hormone (PTH)1 (12) (13) (14) . The studies of Selye (15) and Lehr (16) suggested a role for PTH in the cardiac disease of uremia. These authors found that cardiac lesions predictably occurred in rats after l)ilateral nephrectomy or bilateral ureteral ligation. The lesions were characterized by calcium deposits in the myocardium and the coronary arteries. Administration of PTH enhanced the development of these lesions and parathyroidectomy either inhibited or completely prevented their evolution.
PTH is known to augment entry of calcium into a variety of mammalian cells (17) (18) (19) (20) (21) (22) , and it has been shown that excess blood levels of PTH in uremia are responsible for an increase in the calcium content of many tissues such as skin (23) , cornea (24) , blood vessels (25) , muiscle (26) , brain (27, 28) , and peripheral nerves (29) . PTH apparently exerts a similar effect on the heart. Kraikipanitch et al. (30) demonstrated that calcium content of the myocardium is increased in uremic dogs with intact parathyroid glands and that parathyroidectomy prevented the accumulation of calcium in the heart of the uremic animals.
Excessive accumulation of calcium into the myocardial cells could be harmful to their functional integrity. Indeed, it has been shown that enhanced entry of calcium by catecholamines into cardiac cells can cause necrosis (31) . It is therefore possible that the elevated blood levels of PTH in uremia may adversely affect myocardial function by augmenting calcium entry into the cardiac cells, and in such a manner participate in the overall pathogenesis of the uremic myocardiopathy. The present study was undertaken to examine the effects of PTH on the heart and to investigate the pathways through which PTH interacts with the myocardium.
METHODS A large body of evidence has accumulated indicating that heart cells in culture represent normally functioning muscle cells (32) . The use of heart cells in culture is therefore an appropriate tool for the study of the effect of various agents on the myocardium. Rat heart cells were grown into tissue culture according to the method of Harary and Farley (33) . Wistar rats, 1-4 d old, were decapitated. Their hearts were removed under aseptic conditions and were placed in cold Dulbecco's phosphate-buffered saline (PBS) containing antibiotics. After all the hearts were rinsed, they were transferred to a new petri dish containing PBS and were minced into fragments <1 mm. The mince was transferred to a flask containing a magnetic bar and enough solution of 0.1% Viokase (VioBin Corp., Monticello, Ill.). Dissociation of the heart cells was achieved by incubation at 37°C while stirring for 20 min with a magnetic stirrer. All fragments were allowed to settle, and the supemate, which contained erythrocytes, endothelial cells, and some heart cells, was discarded. A new solution of Viokase was added, and the heart fragments were again incubated with stirring for 20 min. The cell suspension was decanted into chilled sterile screwcap test tubes and kept in ice for 5 min. It was then centrifuged at 1,000 g for 5 min. The dissociation cycle, including incubation and stirring in 0.1% Viokase solution and centrifugation, was repeated for 4-5 times. The cell pellet was then suspended in complete growth medium made of CMRL (Connaught Medical Research Laboratories, Willodale, Ontario, Canada) supplemented with 5% horse serum and 5% fetal calf serum. The preparation of the cells by preferential attachment eliminates a high percentage of fibroblast, and >80% of the cells are myocytes. Cells obtained from hearts of 1-4-d-old rats contain 45-60% myocytes (nondividing cells) and the rest myoblasts (dividing cells) (34) . The viability of the cells was ascertained by trypan blue exclusion method, and >95% of the cells were viable.
Heart cells were counted with Coulter Counter-Electrozone Celloscope (Particle Data Inc., Elmhurst, Ill.), and 1.2 x 106 cells were plated on sterile dishes with 4 ml of complete growth medium. The cells were then grown in an incubator at 37°C for 2 d. 2 h prior to the study of the experimental condition, the old medium was replaced with a fresh one. The frequency of the beating of the heart cells was determined by direct counting, using a stopwatch and an inverted microscope. The time required for 10 beats was determined, and such measurements were repeated 2-4 times; the average was used to calculate the frequency of contraction in beats per minute.
Effect of PTH
The effects of both synthetic 1-34 fragment of PTH (1-34 PTH) (Beckman Instruments Inc., Spinco Div., Palo Alto, Calif.) and of purified bovine intact hormone molecule, 1-84 bPTH (Sigma Chemical Co., St. Louis, Mo.), were examined. Solutions of PTH were made by dissolving the hormone in distilled water. Preliminary studies showed that both moieties of PTH increase the frequency of beats per minute; therefore, the following studies were performed to delineate the interaction between the hormone and the cardiac cells.
Dose-response relationships. The effects of various concentrations of the hormone were examined to determine a dose-response curve and to find the optimal amount of PTH producing the maximum effect. Concentrations of 1, 2.5, 5, 10, 20, and 60 U of 1-34 PTH/ml medium and of 2, 5, 10, 20, 40, and 60 U of 1-84 bPTH/ml medium were used. For each dose level, five to six studies were performed, and the maximum effect during the first 5 min after the addition of PTH to the medium containing 1.3 mM calcium was determined. It was found that 5 U of 1-34 PTH/ml medium and 40 U of 1-84 bPTH/ml medium exert the maximum effects. These amounts were used in all of the studies thereafter. In addition, the effect of 53-84 human PTH (Bachem Inc., Marina Del Rey, Calif.) was studied; 1.2 ug of this preparation is equivalent to 10 U of 1-84 bPTH.
Rapidity with which the effect ofPTH occurs. The effects of both PTH moieties were examined every 30 s during the first 2 min after the addition of the hormone to the medium in five to seven studies.
Long-term effect of PTH. The effects of 1-34 PTH and 1-84 bPTH on the beating of the heart cells were examined at frequent intervals up to 51 h after the addition of the hormone to the medium. Studies were carried out in parallel with and without the hormone. In the studies without PTH, only the vehicle (distilled water) was added to the medium. The heart cells used in each experiment were obtained from the same heart cell population.
Reversibility of the effect of PTH. In four studies, 1-84 bPTH was added to the medium and the beating rate of the heart cells was determined .0.5, 1, 2, 3, and 5 min after the addition of the hormone. The medium was then changed with a fresh one containing no PTH and the beating rate was measured 10 min later. 1-84 bPTH was then added and the beating rate was again evaluated 0.5, 1, 2, 3, and 5 min thereafter.
Effect of inactivated PTH. 1-34 and 1-84 bPTH were inactivated as follows: 10-15 Ag of PTH was dissolved in 60 ,ul 0.15 N acetic acid, and to this solution 40 ,l of 30% vol/vol H202 was added. The solution was incubated at 37°C for 45 min, and reaction was terminated by freezing and lyophilizing. The effects of inactivated 5 U/ml 1-34 PTH and 40 U/ml 1-84 bPTH were examined. Effect of PTH on cyclic AMP production by heart cells. Cyclic AMP production by heart cells was measured before and 0.5, 1, 2, 5, 10, 20, 30, and 60 min after the addition of 1-34 PTH to the medium. At the end of each interval in separate studies, the medium was decanted and the plastic petri dishes were placed on ice. The cells were then denatured with ice-cold 10% trichloroacetic acid and scraped from the dishes. The suspension was centrifuged at 3,000 g for 15 min using Sorval refrigerated centrifuge (DuPont Instruments, Newtown, Conn.). Determinations of cyclic AMP in the supemate were made by radioimmunoassay (35) .
The precipitate was dissolved in 1 N NaOH, and protein content was determined by the method of Lowry et al. (36) . Two experiments, consisting of three studies for each interval of incubation, were performed, for a total of 51 studies.
Effect of various concentrations ofcalcium in medium on the action of PTH. The influence of various concentrations of calcium in the medium (0.2, 0.4, 0.6, and 1.3 mM) on the effect of PTH on the beating rate of the heart cells was examined. 10 studies were performed at each calcium concentration; in 5 of the studies, 1-84 bPTH was added to the medium, whereas the other 5 studies served as control and only vehicle was added to the medium. To prepare lowcalcium media, calcium-free CMRL was supplemented with dialyzed horse and fetal calf sera. The calcium concentration of the mixture was determined and adequate amounts of calcium chloride were added to the medium to obtain the required concentration of calcium. The latter was ascertained by direct measurement as well.
Effect of catecholamines and their interaction with PTH
After determining the base-line values of the beating rate of the heart cells, five sets of studies were performed. First, either a-or B3-adrenergic agents (phenylephrine or isoproterenol, respectively) were added to the medium to provide a concentration of [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] AM and the beating rates were measured at 0.5, 1, 2, 3, and 5 min thereafter. Preliminary studies showed that these concentrations of the agonists produced maximum stimulation of the beating rate of the heart cells. 1-84 bPTH was then added and the beating rates were determined at 0.5, 1,2,3 and 5 min after the addition ofthe hormone. In a second set of similar studies, 1-84 bPTH was added first to the medium, followed by the a-or a-adrenergic agenits.
In the third and fourth sets of studies, the effect of a-or 8-adrenergic blockers (phenoxybenzamine and propranolol, respectively) in a concentration of 10-20 ,uM and their interaction with 1-84 bPTH were examined. Finally, studies were performed to examine whether PTH and catecholamines have a synergistic effect on the beating rates of the heart cells. In these studies, suboptimal doses of 1-84 bPTH (20 U/ml medium) and of catecholamines (5 AM) were used. The effects of PTH alone, catecholamines alone, and those of both together were evaluated in parallel studies, using the same heart cells population.
Effect of A23187 calcium ionophore and its interaction with PTH The A23187 calcium ionophore (kindly supplied by Eli Lilly & Co., Indianapolis, Ind.) was dissolved in dimethylsulfoxide and diluted 1:10 with complete growth media. After determining the base-line values of the beating rate, two sets of studies were performed. First, the ionophore was added to the medium to provide a concentration of 1 ,(M, and the beating rate was determined at 1, 2, 3, and 5 min after the addition of the hormone. In the second set of studies, 1-84 bPTH was added first to the medium, followed by ionophore.
In addition, parallel studies were performed, using the same heart cell population, in which either 1-84 bPTH or ionophore alone or both agents together were added to the culture medium.
culture medium, followed by 1-84 bPTH; the sequence was reversed in the second set of studies.
Effect of uremic sera on heart cells
The effects of uremic sera with and without PTH on the beating rate of the heart cells were examined. Acute uremia was produced by bilateral nephrectomy in intact and parathyroidectomized (PTX) Wistar rats weighing 250 g. Parathyroidectomy was produced with cautery and the success of the procedure was ascertained by a drop in the level of serum calcium of at least 2.0 mg/dl. A group of PTX-nephrectomized rats received intraperitoneal injections of 20 U of 1-84 bPTH twice daily beginning after nephrectomy and until they were killed. All rats were bled 48 h after nephrectomy and sera were prepared. Sera from control rats and from those with uremia replaced the horse serum in the complete growth medium used in these studies. Thus, the medium was made of CMRL supplemented with 10% of the appropriate rat serum and 5% fetal calf serum.
The heart cells were grown in the usual complete growth medium. The basal value of the beating rate was determined and then the medium was changed to the experimental one. In each of the experiments, parallel studies on heart cells of the same population were performed with the medium containing serum, either from normal rats, uremic rats with intact parathyroid glands, PTX-uremic rats, or PTX-uremic rats treated with PTH. The beating rate of the heart cells was evaluated at various intervals up to 30 h.
Statistical analysis
The t test was used for the statistical analysis of the data.
RESULTS
The effects of 1-34 and 1-84 bPTH on the beating of the heart cells are shown in Figs. 1 and 2 and Table I in the beating rate within 30 s of their addition to the medium (Fig. 1) , and this effect lasted for at least 12-24 h (Table I) . Thereafter, the beating rates of the cells in the medium containing PTH was significantly lower than that of the control cells, and the PTHtreated cells ceased to beat earlier than the control ones (Table I) . There was a dose-response relationship between both 1-34 and 1-84 bPTH and their effects on the beating rate. It is of interest that the effect of 1-84 bPTH was significantly (P < 0.01) smaller than that of 1-34 PTH at the lower doses (2-5 U/ml medium) and significantly (P < 0.01) greater at the higher doses (40-60 U/ml medium). The maximum increments in beating rate induced by 1-34 PTH were 53±3.8% (SE) and was achieved with 5 U/ml medium while the maximum increments with 1-84 bPTH were obtained with 40-60 U/ml medium. The carboxy-terminal (53-84) PTH in concentration of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] gg/ml did not stimulate the beating of the heart cells (Table II) . Inactivation of 1-34 and 1-84 bPTH abolished their effects (Table II) .
The effect of 1-84 bPTH on the heart cells was reversible, and the stimulation of beating rate disappeared after removal of PTH from the medium, with beats per minute (113+2.1) returning almost to the initial basal value (102±1.7). A second addition of 1-84 bPTH to the same cells incubated in fresh medium produced a stimulation of beating rate comparable to that observed during the first addition of the hormone (Table III) .
The effect of 1-34 PTH on cyclic AMP production by the heart cells is shown in Fig. 3 . There was a marked and significant (P < 0.01) increment in cyclic AMP production by the heart cells within 30 s of the FIGURE 3 The effect of 1-34 PTH on cyclic AMP production by heart cells. Each line represents one experiment and each point denotes the mean±SE of three studies. The PTH used was 1-84 in a concentration of 20 U/ml medium. The concentration of isoproterenol or phenylephrine was 5 AM. Each datum represents mean±SE of six studies.
the beating rate by bPTH, whether the blockers were added to the medium before or after the addition of bPTH.
The simultaneous addition of suboptimal doses of 1-84 bPTH and a-adrenergic agonist (isoproterenol) produced significantly (P < 0.01) greater increments in beating rate than the sum of the increments obtained by PTH or isoproterenol alone (Table IV) . In contrast, simultaneous addition of PTH and a-adrenergic agonist (phenylephrine) did not produce greater stimulation of the beating rate than the sum of the stimulation produced by PTH and phenylephrine alone (Table VI) . The summary of the results of the studies on the interaction between PTH, calcium ionophore, and verapamil is given in Tables VII and VIII, and sentative experiments are depicted in Fig. 5 . Calcium ionophore produced stimulation of the beating rate of the heart cells similar to that observed with bPTH. The addition of calcium ionophore to cells already The PTH used was 1-84 in a concentration of40 U/ml medium. The concentration of calcium ionophore was 1 ,uM. Each datum represents mean+SE of five studies.
stimulated by PTH produced no further stimulation of the beating rate. Further, the stimulation of the beating rate of the heart cells by PTH or calcium ionophore alone or together was not different (Table VIII) . Addition of verapamil to the medium was associated with gradual but significant decline in the beating rates of the heart cells. The subsequent addition of bPTH to the medium already containing verapamil did not produce stimulation of heart cells. When verapamil was added to PTH-stimulated heart cells, the beating rate declined within 1 min to the original base-line values and continued to fall gradually during the ensuing 5 min.
The effects of uremic sera with and without PTH on the beating rate of the heart cells are given in Table  IX and Fig. 6 . Uremic sera from nephrectomized rats with intact parathyroid glands produced significant (P < 0.05-0.01) stimulation of the beating rate for 12-20 h. Thereafter, the beating rate started to decline and was significantly lower than that of the control cells. These observations are similar to those seen during the addition of either 1-34 or 1-84 bPTH to the medium (Table I) . In contrast, uremic sera from . IA23187 IPTH nephrectomized-PTX rats did not affect the beating rate of the heart cells; the beating of heart cells was similar in the presence ofboth control serum and serum from PTX-uremic rats. Finally, uremic serum obtained from PTX-uremic rats treated with 1-84 bPTH produced significant (P < 0.05-0.01) stimulation of the heart cells for 10-20 h, followed by slowing of the beating rate; these observations are similar to those noted after the addition of 1-34 or 1-84 bPTH or in the presence of serum from uremic rats with intact parathyroid glands. the frequency of the beating of the heart cells. This TIME (MINUTES) effect occurred almost immediately, continued for FIGURE 5 Representative studies on the interaction between many hours as long as the hormone was present, was PTH and calcium ionophore A23187 (upper panel) and PTH reversible, and was dose dependent. The demonand verapamil (lower panel) on the beating rates of heart cells. stration that the inactivation of the PTH abolished its effect on the heart cells is consistent with the action being related to the biologic activity of the hormone and not to a contaminant of the hormone preparations. The reason for the greater effect of bPTH than that of 1-34 PTH is not obvious. This observation would suggest that the biologic activity of the intact hormone on the heart is greater than its amino-terminal fragment, and such a phenomenon could be related to a possible effect of the carboxy-terminal fragment on the heart. Our finding that 53-84 PTH did not affect the beating rate does not necessarily vitiate a role for carboxy-terminal PTH on the heart. It is possible that bigger fragment(s) other than the 53-84 are important.
It is well-documented that an increase in the calcium delivery to the myofilaments is responsible for the contraction of heart cells. Indeed, augmented calcium influx occurs in association with positive inotropism accompanied by increased frequency of contraction (37) (38) (39) , catecholamine adininistration (40, 41) , and digitalis (42, 43) . Several lines of evidence indicate that the effect of PTH on the heart cells is also calcium dependent and is mediated through the augmentation of calcium availability to the heart cells. First, PTH in media containing lower calcium concentration enhanced the beating of the heart cells to levels similar to those seen in media with the next higher calcium concentration; these results are consistent with PTH making more calcium available to the cardiac cells. Supporting our data are the results of Harary et al. (44) , which evaluated the effect of noradrenaline, an agent known to augment calcium entry into the heart cells (40) , on the beating rate. They foutnd that the frequency of beating decreased upon reducing the calcium concentration in the media, and beating stopped at 0.1 mM Ca; in the presence of noradrenaline, beating was sustained even at a concentration of 30 AM Ca, suggesting that the agent made more calcium available to the cells even at low concentration in media. Second, calcium ionophore produced an effect on the heart cells similar to that induced by PTH, and neither of the agents in the presence of the other could cause further increments in the beating rate ofthe heart cells. Finally, verapamil, which blocks movement of calcium from the media into the cells (45) , abolished the effect of PTH. Our conclusion is in line with other observations demonstrating that PTH enhances entry of calcium in other mammalian cells (17) (18) (19) , and that excess PTH leads to accumulation of calcium in many tissues (23) (24) (25) (26) (27) (28) (29) , including the heart (30) .
Recently, Lhoste et al. (46) evaluated the effect of the amino-terminal fragment of PTH (1-34 PTH) on the isometric contractile force of isolated guinea pig auricles. They found that PTH inhibited the depressant effect of both 1-and d-propranolol on the contractile force of the auricles. Since both of these agents have membrane-stabilizing activity and since the l-isomere has no adrenergic blocking effect, the influence of propranolol is therefore at least partly mediated by its membrane-stabilizing action, which would result in decreasing calcium movement into the myocardial cells (47) . Thus, the authors suggested that PTH antagonzes the depressant effect of propranolol on the myocardium by augmenting calcium entry into the cells of the heart. Further support for their claim was provided by their finding that PTH also partially overcame the depressant effect of verapamil on the contractile force of the auricles. These observations agree with our data and provide additional evidence for an interaction between PTH and the heart that is probably mediated by inovement of calcium into the heart cells.
The increased entry of calcium into the heart cells under the influence of PTH is likely a consequence of two processes. First, the hormone may directly enhance calcium influx; such a phenomenon has been demonstrated in many mammalian cells (17) (18) (19) (20) (21) (22) . Second, the stimulation of cyclic AMP production may augment calcium movement into the cells. Several lines of evidence support this notion. Available data indicate that calcium influx into the heart occurs during a slow inward current, which has the characteristics expected of a calcium current (48) (49) (50) . Butyryl derivatives of cyclic AMP increase the slow inward current (51, 52) , and dibutyryl cyclic AMP enhances fluxes of tracer calcium into heart cells (53) . Finally, agents such as histamine, theophylline, or papaverine, which augment intracellular cyclic AMP of myocardium, promote action potentials that are dependent on slow inward current at a time when fast sodium channels are blocked or iiiactivted (54) (55) (56) . The effect of cyclic AMP on calcium movement into the cell is probably mediated through phosphorylation of the plasma membrane (57) . A role for the increased production of cyclic AMP by PTH on the increased beating of the heart cells is also supported by the observations of Krause et al. (58) (60, 61) , which in turn increases the degradation of cyclic AMP, leading to a decrease in the phosphorylation of SR membrane (62) . This sequence of events would reduce the uptake of calcium by the SR and prevent continued fall in cytosolic calciumn. Thus, as has been suggested by Harary and Wallace (63) , it appears that calcium in myocardial cytosol may regulate its own concentration by a feedback control mechanism on cyclic AMP. Indeed, Harary et al. (44) provided data supporting this notion. Our observation that PTH produced an immediate rise in cyclic AMP production, which then quickly fell to levels that remained stable but significantly higher than the basal values, are consistent with a new steady state produced by PTH. The hormone increased the production of cyclic AMP and augmented calcium entering into the cells, and through the feedback control process between calcium and cyclic AMP, a new steady state ensued with higher intracellular calcium and cyclic AMP and increased frequency of beating of the heart cells.
Catecholamines are known to affect cardiac contraction (40, 41) and to increase beating ofheart cells (44) by augmenting calcium entry into the myocardial cells. Certain data in our studies indicate that the channels for calcium entry into heart cells and/or the processes responsible for such movement under the influence of PTH are different from those affected by catecholamines. PTH augmented the beating rate by cells already stimulated with either a-or,8-adrenergic agents, and the latter produced further increments in the beating rate of the cells exposed to PTH. In fact, the interaction between PTH and the a-adrenergic agent isoporterenol appeared to be synergistic. Furthermore, a-or ,3-blockers did not affect the response of the heart cells to PTH. Thus, it appears that these receptors are not the site of action of PTH.
Fleckenstein (64) has demonstrated that calcium overload of the myocardial cells induced by catecholamines, was associated with a deficiency of highenergy phosphate compound; there was a significant fall in cellular ATP content secondary to 1)oth increased ATP consumption and decreased ATP synthesis. Furthermore, Seraydarian et al. (65) have showni that maintenance of normal ATP level is critical for spontaneous beating of heart cells in culture, and a decrease of 30-60% in cellular ATP was associated with cessation of beating. It is therefore reasonable to suggest that calcium overload of the myocardial cells under the prolonged influence of PTH would be associated with a decrease in their ATP coniteint. Such an event would provide an explanationi for the observed decline and final cessation of the beating of the cells after several hours of exposure to PTH.
Our data are consistent with the notion that the elevated blood levels of PTH in uremia enhaince calcium influx into the myocardiumii and affect its fuinction. It is also possible that other compounds retained or produced in excess by the uremic patienits have effects on the heart adverse as those of PTH. However, our studies with uremic sera with and without excess endogenous or exogenous PTH clearly demonstrate that uremic sera have no effect on the beating rate of the heart cell unless they conltainl PTH. Lhoste et al. (46) evaluated the effect of sera obtained from uremiiic patients with secondary hyperparathyroidism and from uremic patients previously subjected to parathyroidectomy on the contraction of the isolated auticles of the guinea pig. They found that only the uremic sera with excess PTH produced significant inhibition of the depressant effect of propranolol on the contraction of the auricles. Thus, our data and those of Lhoste et al. (46) indicate that it is the PTH, and not other compounids in the tiremic sera, that affects myocardial function.
Recently, Druieke et al. (66) reported marked improvement in left ventricular functioni after parathyroidectomy in 22 dialysis patients with secondary hyperparathyroidism. These observations provide further support for the notion that the elevated blood levels of PTH in patients with uremia may adversely affect myocardial function and cotuld, at least in past, be responisible for uremic myocardiopathy. Finally, the interaction between catecholamines andl PTH on the heart, as demonstrated in our study, may expose patients with renal failuire to double jeopardy, since these patients mlay have elevated blood levels of catecholamines (67-69) in addition to secoindary hyperparathyroidism.
